Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Vertex Pharmaceuticals Incorporated

8.3% sales growth and 40.2% return on equity

Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis.

Vertex Pharmaceuticals Incorporated’s sales growth this year is anticipated to be 53.5% and 13% for next year.

Year-on-year quarterly revenue growth grew by 62%, now sitting on 5.99B for the twelve trailing months.

Vertex Pharmaceuticals Incorporated’s sales growth for the next quarter is 8.3%. The company’s growth estimates for the present quarter and the next is 52.4% and 4.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 40.2%.

Volatility

Vertex Pharmaceuticals Incorporated’s last day, last week, and last month’s average volatility was a negative 0.44%, a positive 1.00%, and a positive 0.06%, respectively.

Vertex Pharmaceuticals Incorporated’s last day, last week, and last month’s high and low average amplitude percentage was 2.04%, 2.95%, and 2.61%, respectively.

Vertex Pharmaceuticals Incorporated’s Stock Yearly Top and Bottom Value

Vertex Pharmaceuticals Incorporated’s stock is valued at $237.59 at 13:22 EST, way under its 52-week high of $306.08 and way above its 52-week low of $197.47.

Vertex Pharmaceuticals Incorporated’s Moving Average

Vertex Pharmaceuticals Incorporated’s value is above its 50-day moving average of $231.53 and below its 200-day moving average of $249.38.

2. BioDelivery Sciences International, Inc.

14.1% sales growth and 18.1% return on equity

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products in the United States and internationally.

BioDelivery Sciences International, Inc.’s sales growth this year is anticipated to be 37.3% and 25.9% for next year.

Year-on-year quarterly revenue growth grew by 30.1%, now sitting on 145.94M for the twelve trailing months.

BioDelivery Sciences International, Inc.’s sales growth for the next quarter is 14.1%. The company’s growth estimates for the ongoing quarter and the next is 700% and 60%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.1%.

Volatility

BioDelivery Sciences International, Inc.’s last day, last week, and last month’s average volatility was a negative 2.38%, a negative 1.21%, and a negative 0.37%, respectively.

BioDelivery Sciences International, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 3.35%, 4.55%, and 5.01%, respectively.

BioDelivery Sciences International, Inc.’s Stock Yearly Top and Bottom Value

BioDelivery Sciences International, Inc.’s stock is valued at $4.13 at 13:22 EST, way under its 52-week high of $5.98 and way higher than its 52-week low of $2.85.

BioDelivery Sciences International, Inc.’s Moving Average

BioDelivery Sciences International, Inc.’s worth is under its 50-day moving average of $4.34 and above its 200-day moving average of $4.08.

3. Abbott Laboratories

24.3% sales growth and 10.57% return on equity

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide.

Abbott Laboratories’s sales growth this year is expected to be 6.1% and 13.5% for next year.

Year-on-year quarterly revenue growth grew by 9.6%, now sitting on 32.22B for the twelve trailing months.

Abbott Laboratories’s sales growth for the next quarter is 24.3%. The company’s growth estimates for the ongoing quarter and the next is 42.1% and 60%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.57%.

Volatility

Abbott Laboratories’s last day, last week, and last month’s average volatility was a positive 1.15%, a negative 0.05%, and a positive 0.17%, respectively.

Abbott Laboratories’s last day, last week, and last month’s high and low average amplitude percentage was 2.04%, 2.37%, and 1.98%, respectively.

Abbott Laboratories’s Stock Yearly Top and Bottom Value

Abbott Laboratories’s stock is valued at $111.30 at 13:22 EST, below its 52-week high of $115.14 and way higher than its 52-week low of $61.61.

Abbott Laboratories’s Moving Average

Abbott Laboratories’s value is above its 50-day moving average of $108.65 and higher than its 200-day moving average of $105.67.

4. ManTech International Corporation

5.5% sales growth and 8.57% return on equity

ManTech International Corporation provides technology solutions and services for U.S. defense, intelligence community, and federal civilian agencies worldwide.

ManTech International Corporation’s sales growth this year is anticipated to be 12.8% and 6% for next year.

Year-on-year quarterly revenue growth grew by 9.8%, now sitting on 2.48B for the twelve trailing months.

ManTech International Corporation’s sales growth for the next quarter is 5.5%. The company’s growth estimates for the ongoing quarter and the next is 2.6% and 4.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.57%.

Volatility

ManTech International Corporation’s last day, last week, and last month’s average volatility was 3.02%, 0.75%, and 1.02%, respectively.

ManTech International Corporation’s last day, last week, and last month’s high and low average amplitude percentage was 3.42%, 2.52%, and 2.94%, respectively.

ManTech International Corporation’s Stock Yearly Top and Bottom Value

ManTech International Corporation’s stock is valued at $101.20 at 13:22 EST, below its 52-week high of $101.35 and way higher than its 52-week low of $55.25.

ManTech International Corporation’s Moving Average

ManTech International Corporation’s worth is way higher than its 50-day moving average of $88.08 and way higher than its 200-day moving average of $75.45.

5. Palomar Holdings, Inc.

29.2% sales growth and 6.66% return on equity

Palomar Holdings, Inc. provides specialty property insurance.

Palomar Holdings, Inc.’s sales growth this year is anticipated to be 43.6% and 35.9% for next year.

Year-on-year quarterly revenue growth grew by 47.7%, now sitting on 160.79M for the twelve trailing months.

Palomar Holdings, Inc.’s sales growth for the next quarter is 29.2%. The company’s growth estimates for the current quarter and the next is a negative 68.7% and 6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.66%.

Volatility

Palomar Holdings, Inc.’s last day, last week, and last month’s average volatility was a negative 4.36%, a negative 0.20%, and a positive 1.00%, respectively.

Palomar Holdings, Inc.’s last day, last week, and last month’s high and low average amplitude percentage was 6.04%, 3.72%, and 3.97%, respectively.

Palomar Holdings, Inc.’s Stock Yearly Top and Bottom Value

Palomar Holdings, Inc.’s stock is valued at $98.06 at 13:22 EST, way under its 52-week high of $121.87 and way above its 52-week low of $39.21.

Palomar Holdings, Inc.’s Moving Average

Palomar Holdings, Inc.’s value is way above its 50-day moving average of $83.58 and above its 200-day moving average of $91.35.

6. American Tower Corporation

7.3% sales growth and 34.18% return on equity

American Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of approximately 181,000 communications sites.

American Tower Corporation’s sales growth this year is anticipated to be 5.2% and 8.4% for next year.

Year-on-year quarterly revenue growth grew by 3%, now sitting on 7.84B for the twelve trailing months.

American Tower Corporation’s sales growth for the next quarter is 7.3%. The company’s growth estimates for the ongoing quarter and the next is a negative 0% and 47.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.18%.

Volatility

American Tower Corporation’s last day, last week, and last month’s average volatility was a positive 2.28%, a negative 0.21%, and a positive 0.06%, respectively.

American Tower Corporation’s last day, last week, and last month’s high and low average amplitude percentage was 2.91%, 2.36%, and 2.02%, respectively.

American Tower Corporation’s Stock Yearly Top and Bottom Value

American Tower Corporation’s stock is valued at $219.89 at 13:22 EST, way below its 52-week high of $272.20 and way above its 52-week low of $174.32.

American Tower Corporation’s Moving Average

American Tower Corporation’s worth is under its 50-day moving average of $221.03 and below its 200-day moving average of $240.82.

LEAVE A REPLY

Please enter your comment!
Please enter your name here